Elina Teicher

Summary

Country: France

Publications

  1. doi request reprint Enfuvirtide: a safe and effective antiretroviral agent for human immunodeficiency virus-infected patients shortly after liver transplantation
    Elina Teicher
    Département Médecine Interne et Infectiologie, AP HP Hopital Paul Brousse, Villejuif, France
    Liver Transpl 15:1336-42. 2009
  2. doi request reprint Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft
    Teresa M Antonini
    aAP HP, Hopital Paul Brousse, Centre Hépato Biliaire bUniversity Paris Sud, UMR S 785 cInserm, Unite 785, Villejuif dAP HP, HôpitalBicêtre, Pharmacie Clinique eAP HP, Hopital Bicetre, Service de Medecine Interne, Immunologie et Maladies Infectieuses, Le Kremlin Bicêtre fAP HP Hôpital Paul Brousse, Service de Virologie gAP HP, Hopital Paul Brousse, Service Anatomie Pathologique hAP HP, Hopital Paul Brousse, Pharmacie Clinique, Villejuif iAP HP, GH Xavier Bichat Claude Bernard, Laboratoire de Toxicologie et Pharmacocinétique jUniversité Paris, Paris kHepatinov, Villejuif, France
    AIDS 27:2655-7. 2013
  3. doi request reprint Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity
    Mariagrazia Tateo
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    AIDS 23:1069-76. 2009
  4. doi request reprint Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation
    Mylene Sebagh
    Laboratoire d Anatomie Pathologique, Assistance Publique Hopitaux de Paris, Villejuif, France
    Liver Transpl 17:798-808. 2011
  5. doi request reprint A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients
    Mariagrazia Tateo
    Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
    Liver Transpl 14:1194-8. 2008
  6. ncbi request reprint Coronary heart disease in HIV-infected individuals
    Daniel Vittecoq
    Service des Maladies Infectieuses, Hopital Paul Brousse, Villejuif, France
    Adv Cardiol 40:151-62. 2003
  7. ncbi request reprint Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era
    Daniel Vittecoq
    Service des Maladies Infectieuses et de Médecine Interne, Hopital Paul Brousse, Villejuif, France
    AIDS 17:S70-6. 2003
  8. ncbi request reprint Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus
    Jean Charles Duclos-Vallée
    Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
    Hepatology 47:407-17. 2008
  9. ncbi request reprint [Liver transplantation for patients infected with both HIV and HCV or HIV and HBV]
    Jean Charles Duclos-Vallée
    Département des Maladies du Foie et INSERM U785, Unité de maladies infectieuses, Universite Paris XI, Centre Hepato Biliaire, Hopital Paul Brousse, 12 14, avenue Paul Vaillant Couturier, 94804, Villejuif, France
    Med Sci (Paris) 23:723-8. 2007
  10. ncbi request reprint Coronary artery disease in HIV infected patients
    Lelia Escaut
    Service des Maladies Infectieuses, Hopital Paul Brousse, 12 14 avenue Paul Vaillant Couturier, 94804, Villejuif, France
    Intensive Care Med 29:969-73. 2003

Collaborators

Detail Information

Publications10

  1. doi request reprint Enfuvirtide: a safe and effective antiretroviral agent for human immunodeficiency virus-infected patients shortly after liver transplantation
    Elina Teicher
    Département Médecine Interne et Infectiologie, AP HP Hopital Paul Brousse, Villejuif, France
    Liver Transpl 15:1336-42. 2009
    ..Moreover, the lack of liver toxicity renders this drug valuable in the event of a severe HCV recurrence...
  2. doi request reprint Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft
    Teresa M Antonini
    aAP HP, Hopital Paul Brousse, Centre Hépato Biliaire bUniversity Paris Sud, UMR S 785 cInserm, Unite 785, Villejuif dAP HP, HôpitalBicêtre, Pharmacie Clinique eAP HP, Hopital Bicetre, Service de Medecine Interne, Immunologie et Maladies Infectieuses, Le Kremlin Bicêtre fAP HP Hôpital Paul Brousse, Service de Virologie gAP HP, Hopital Paul Brousse, Service Anatomie Pathologique hAP HP, Hopital Paul Brousse, Pharmacie Clinique, Villejuif iAP HP, GH Xavier Bichat Claude Bernard, Laboratoire de Toxicologie et Pharmacocinétique jUniversité Paris, Paris kHepatinov, Villejuif, France
    AIDS 27:2655-7. 2013
    ..A sustained virological response was achieved after 48 weeks of anti-HCV therapy. Drug-drug interactions between antiretroviral therapy, immunosuppressive agents and anti-HCV therapy could be managed. ..
  3. doi request reprint Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity
    Mariagrazia Tateo
    AP HP Hopital Paul Brousse, Centre Hepato Biliaire, Villejuif, France
    AIDS 23:1069-76. 2009
    ..The outcome of liver transplantation in HBV-HIV-coinfected patients is poorly understood in terms of survival rate, HBV reactivation and mitochondrial toxicity on the liver graft...
  4. doi request reprint Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation
    Mylene Sebagh
    Laboratoire d Anatomie Pathologique, Assistance Publique Hopitaux de Paris, Villejuif, France
    Liver Transpl 17:798-808. 2011
    ..The histological resolution of iVOD/SOS after increase in immunosuppression suggests an immune-mediated origin. Better optimization of immunosuppression may be a curative treatment...
  5. doi request reprint A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients
    Mariagrazia Tateo
    Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
    Liver Transpl 14:1194-8. 2008
    ..We describe here our experience concerning 3 HIV-infected patients with severe complications of nodular regenerative hyperplasia treated with liver transplantation...
  6. ncbi request reprint Coronary heart disease in HIV-infected individuals
    Daniel Vittecoq
    Service des Maladies Infectieuses, Hopital Paul Brousse, Villejuif, France
    Adv Cardiol 40:151-62. 2003
  7. ncbi request reprint Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era
    Daniel Vittecoq
    Service des Maladies Infectieuses et de Médecine Interne, Hopital Paul Brousse, Villejuif, France
    AIDS 17:S70-6. 2003
    ..To assess the incidence and the clinical features of coronary heart disease in HIV-infected patients. To assess atherosclerosis risk factors in this population...
  8. ncbi request reprint Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus
    Jean Charles Duclos-Vallée
    Centre Hepato Biliaire, AP HP Hopital Paul Brousse, Villejuif, France
    Hepatology 47:407-17. 2008
    ..03; risk ratio, 1.08; 95% confidence interval, 1.01, 1.15). Using the Kaplan-Meier method, the progression to fibrosis >or= F2 was significantly higher in the coinfected group (P < 0.0001)...
  9. ncbi request reprint [Liver transplantation for patients infected with both HIV and HCV or HIV and HBV]
    Jean Charles Duclos-Vallée
    Département des Maladies du Foie et INSERM U785, Unité de maladies infectieuses, Universite Paris XI, Centre Hepato Biliaire, Hopital Paul Brousse, 12 14, avenue Paul Vaillant Couturier, 94804, Villejuif, France
    Med Sci (Paris) 23:723-8. 2007
    ..Understanding HCV recurrence mechanisms, and preventing and treating of HCV recurrence are major future challenges...
  10. ncbi request reprint Coronary artery disease in HIV infected patients
    Lelia Escaut
    Service des Maladies Infectieuses, Hopital Paul Brousse, 12 14 avenue Paul Vaillant Couturier, 94804, Villejuif, France
    Intensive Care Med 29:969-73. 2003
    ..To assess the incidence, clinical features, treatment, and follow-up of coronary events in HIV-infected patients over a period of 5 years...